Repurposing methuosis-inducing anticancerAU : Pl drugs for anthelmintic therapy

Abstract

Drug-resistant parasitic nematodes pose a grave threat to plants, animals, and humans. An innovative paradigm for treating parasitic nematodes is emphasized in this opinion. This approach relies on repurposing methuosis (a death characterized by accumulation of large vacuoles) inducing anticancer drugs as anthelmintics. We review drugs/chemicals that have shown to kill nematodes or cancerous cells by inducing multiple vacuoles that eventually coalesce and rupture. This perspective additionally offers a succinct summary on Struclinstancesof ture–Activity }antihelminthic Relationship }and}anthelminthic (SAR) of}methuosis-inducing havebeenreplacedwith}anthelmintic small molecules. }toenforceconsistencythroughoutthetext This strategy :Plea holds promise for the development of broad-spectrum anthelmintics, shedding light on shared molecular mechanisms between cancer and nematodes in response to these inducers, thereby potentially transforming both therapeutic domains.